Concepedia

Golnaz Moazami

GM

Statistics

Publications

7

Citations

328

H-Index

7

Active since

1995

Affiliations

Columbia University Irving Medical Center(Current)

NewYork–Presbyterian Hospital

New York University

National Cancer Institute

University Hospital Leipzig

Golnaz Moazami is an author at Columbia University Irving Medical Center specializing in pre-clinical pharmacology, health sciences, and cancer research.

Top concepts

Publications per year

1995–2022

7

Publications

7

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Andrew B. Lassman, Stephanie L. Pugh, Tony J. C. Wang et al. · Neuro-Oncology · 2022 · 131 citations · Full text

Evaluation of a Deep Learning System For Identifying Glaucomatous Optic Neuropathy Based on Color Fundus Photographs

Lama A. Al‐Aswad, Rahul Kapoor, Chia.kai Chu et al. · Journal of Glaucoma · 2019 · 51 citations · Full text

Interferon Treatment of Mooren's Ulcers Associated With Hepatitis C

Golnaz Moazami, James D. Auran, George J. Florakis et al. · American Journal of Ophthalmology · 1995 · 50 citations · Full text

Prominent Proptosis in Childhood Thyroid Eye Disease

Grant T. Liu, Katrinka L. Heher, James A. Katowitz et al. · Ophthalmology · 1996 · 30 citations

ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM)

Andrew B. Lassman, Stephanie L. Pugh, Tony Wang et al. · Neuro-Oncology · 2019 · 25 citations · Full text

, , +22

1–5 of 7